People: PURE Biosciences Inc (PURE.PK)

PURE.PK on OTC Markets Group

0.44USD
21 May 2013
Price Change (% chg)

$0.14 (+46.67%)
Prev Close
$0.30
Open
$0.31
Day's High
$0.60
Day's Low
$0.30
Volume
318,847
Avg. Vol
78,074
52-wk High
$3.99
52-wk Low
$0.22

Search Stocks

Summary

Name Age Since Current Position

Michael Krall

 60 Chairman of the Board, President, Chief Executive Officer, Interim Chief Financial Officer

Donna Singer

 42 1998 Executive Vice President, Director

Dennis Brovarone

 56 1996 Independent Director

John Carbone

 50 2009 Independent Director

Paul Maier

 65 2008 Independent Director

Dave Pfanzelter

 2013 Independent Director

Don Markley

 Senior Vice President of Lippert/Heilshorn & Associates
» Insider Trading

Biographies

Name Description

Michael Krall

 Mr. Michael L. Krall is Chairman of the Board, President, Chief Executive Officer, Interim Chief Financial Officer of Pure Bioscience, Inc. Mr. Krall is founder. Additionally, he has held the positions of President, CEO and Chairman of the Board since 1993, and is an inventor or co-inventor on the majority of SDC patent portfolio. Mr. Krall has unparalleled knowledge of technology, operations and relationships with company's partners, which he has acquired through his more than seventeen years of service to, and leadership of, the Company.

Donna Singer

 Ms. Donna M. Singer is Executive Vice President, Director of Pure Bioscience, Inc. She has been a director since 1998. From 1996 to 1998, Ms. Singer served as Vice President of Operations.

Dennis Brovarone

 Mr. Dennis Brovarone is Independent Director of PURE Bioscience, Inc., since April 1996. Mr. Brovarone has been practicing corporate and securities law since 1986 and as a sole practitioner since 1990, specializing in U.S. public companies. He was elected to the Board in April 1996, and acted as counsel at the time of company's initial public offering in that year. Mr. Brovarone has served as securities counsel since that time.

John Carbone

 Dr. John J. Carbone, MD, is Independent Director of PURE Bioscience, Inc., since March 2009. Dr. Carbone is a Board Certified Orthopedic Surgeon and a Fellow of the American Academy of Orthopedic Surgeons. Since 2004, he has served as the Director, Orthopedic Spine Services at Harbor Hospital in Baltimore, Maryland. Dr. Carbone earned a bachelor's degree in engineering from The United States Merchant Marine Academy in 1983. He served as a marine engineer for Military Sealift Command until 1988, and as a lieutenant in the United States Naval Reserve until 1993. He received his medical degree from the University of Maryland School of Medicine in 1992, and completed his orthopedic residency training and his reconstructive spinal surgery fellowship at The Johns Hopkins Hospital. Dr. Carbone has been a senior officer of two privately held orthopedic research and design companies, and is the inventor of several patented orthopedic devices and methods.

Paul Maier

 Mr. Paul V. Maier is Independent Director of Pure Bioscience, Inc., since 2008. Since November 2009, Mr. Maier has served as Chief Financial Officer of Sequenom, Inc., a life sciences company based in San Diego, California. Previously, he served as Vice President, Chief Financial Officer and became Senior Vice President, Chief Financial Officer of Ligand Pharmaceutical Inc., a biotechnology company, from 1992 to 2007. Prior to Ligand Pharmaceutical, Mr. Maier served as Vice President, Finance at DFS West, a division of DFS Group, L.P., a private multinational retailer from October 1990 to October 1992. From February 1990 to October 1990, Mr. Maier served as Vice President and Treasurer of ICN Pharmaceuticals, Inc., a pharmaceutical and biotechnology research products company. Mr. Maier held various positions in finance and administration at SPI Pharmaceuticals, Inc., a biotechnology company and a publicly held subsidiary of ICN Pharmaceuticals Group, from 1984 to 1988, including Vice President, Finance from February 1984 to February 1987. Mr. Maier earned an M.B.A. from Harvard Graduate School of Business and a B.S. from Pennsylvania State University. Mr. Maier also serves on the boards of directors of International Stem Cell Corp. and Talon Therapeutics, Inc., both publicly-held biotechnology companies.

Dave Pfanzelter

 Mr. Dave Pfanzelter is appointed as the Independent Director of Pure Biosciences, Inc. Previously Mr. Pfanzelter served as senior vice president of Kellogg Company, president of Kellogg’s Specialty Channels and president of Kellogg Canada since May 2004, while also serving as part of the Kellogg Executive Committee and Global Leadership Team. Mr. Pfanzelter began his foodservice career in 1975 with Oscar Mayer Foods Corporation serving in several key sales and marketing positions, including director of marketing and national sales manager. In 1995, he was appointed vice president, sales of Kraft Foodservice, representing the combined manufactured brands of Oscar Mayer, General Foods and Kraft Foods. In 1998 Mr. Pfanzelter joined Keebler, serving as vice president and general manager of the food service division prior to Keebler’s acquisition by Kellogg in 2001. Since 1998, Mr. Pfanzelter has been on the board of directors of Doctor’s Associates, the parent company of Subway Restaurants, the nation’s restaurant chain. In February 2012, Mr. Pfanzelter joined Wrigley Foods Advisory Board of Directors. He also served on the Board of the International Food Service Manufacturer’s Association as chairman and member of its executive committee.

Don Markley

Basic Compensation

Name Fiscal Year Total

Michael Krall

 479,571

Donna Singer

 264,435

Dennis Brovarone

 --

John Carbone

 --

Paul Maier

 --

Dave Pfanzelter

 --

Don Markley

 --
As Of 30 Jul 2011

Options Compensation

Name Options Value

Michael Krall

 1,885,493 1,399,045

Donna Singer

 1,398,209 959,554

Dennis Brovarone

 0 0

John Carbone

 0 0

Paul Maier

 0 0

Dave Pfanzelter

 0 0

Don Markley

 0 0

Insider Trading

Name Shares Traded Price

CARBONE JOHN J

 13,710 $0.38

BROVARONE DENNIS

 13,710 $0.38

MAIER PAUL V

 13,710 $0.38

BARNHILL GREGORY HURD

 13,710 $0.38

BARNHILL GREGORY HURD

 50,000 $0.78

BARNHILL GREGORY HURD

 25,000 $0.89
» Full list on Insider Trading
Search Stocks